233 related articles for article (PubMed ID: 15904508)
1. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V
BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries.
Tai P; Yu E; Vinh-Hung V; Cserni G; Vlastos G
BMC Cancer; 2004 Sep; 4():60. PubMed ID: 15345027
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methods.
Tai P; Yu E; Shiels R; Tonita J
BMC Cancer; 2005 Jan; 5():13. PubMed ID: 15683543
[TBL] [Abstract][Full Text] [Related]
4. Cure fraction estimation from the mixture cure models for grouped survival data.
Yu B; Tiwari RC; Cronin KA; Feuer EJ
Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term cause-specific survival of patients with inflammatory breast cancer.
Tai P; Yu E; Shiels R; Pacella J; Jones K; Sadikov E; Mahmood S
BMC Cancer; 2005 Oct; 5():137. PubMed ID: 16242046
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models.
Mould RF; Lederman M; Tai P; Wong JK
Phys Med Biol; 2002 Nov; 47(22):3893-924. PubMed ID: 12476973
[TBL] [Abstract][Full Text] [Related]
8. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
9. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
Stedman MR; Feuer EJ; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
[TBL] [Abstract][Full Text] [Related]
10. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
11. Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79.
Ries LG; Pollack ES; Young JL
J Natl Cancer Inst; 1983 Apr; 70(4):693-707. PubMed ID: 6572758
[TBL] [Abstract][Full Text] [Related]
12. Cure of cancer for seven cancer sites in the Flemish Region.
Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
[TBL] [Abstract][Full Text] [Related]
13. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
14. A minimum version of log-rank test for testing the existence of cancer cure using relative survival data.
Yu B
Biom J; 2012 Jan; 54(1):45-60. PubMed ID: 22213092
[TBL] [Abstract][Full Text] [Related]
15. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
17. Proportion cured models applied to 23 cancer sites in Norway.
Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
[TBL] [Abstract][Full Text] [Related]
18. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
[TBL] [Abstract][Full Text] [Related]
20. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]